Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab
Go back to Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1160.95 +24.58 (2.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1136.37 | 52 Week High | $88.16 | |||
| Open | $1139.71 | 52 Week Low | $67.88 | |||
| Day High | $1170.12 | P/E | 268.74 | |||
| Day Low | $1125.64 | EPS | $4.32 | |||
| Volume | 2,764,755 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 26.17 --26.17 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $37.39 | |||
| Open | $0.00 | 52 Week Low | $28.25 | |||
| Day High | $26.48 | P/E | 15.86 | |||
| Day Low | $25.79 | EPS | $1.65 | |||
| Volume | 45,251,826 | |||||
